Lysophosphatidic acid receptor inhibition as a new multipronged treatment for rheumatoid arthritis.
Pharmacological inhibition of LPA1 receptor in the K/BxN serum-transfer arthritis model led to reduction of severity of arthritis involving multiple mechanisms, increased apoptosis, reduced inflammatory mediators and proteins involved in bone remodelling, that show LPA1 as … Leer más